Advanced search
1 file | 249.16 KB Add to list

Current methods for inducing pluripotency in somatic cells

(2013) ADVANCED MATERIALS. 25(20). p.2765-2771
Author
Organization
Abstract
The groundbreaking discovery of reprogramming fibroblasts towards pluripotency merely by introducing four transcription factors (OCT4, SOX2, KLF4 and c-MYC) by means of retroviral transduction has created a promising revolution in the field of regenerative medicine. These so-called induced pluripotent stem cells (iPSCs) can provide a cell source for disease-modelling, drug-screening platforms, and transplantation strategies to treat incurable degenerative diseases, while circumventing the ethical issues and immune rejections associated with the use of non-autologous embryonic stem cells. The risk of insertional mutagenesis, caused both by the viral and transgene nature of the technique has proven to be the major limitation for iPSCs to be used in a clinical setting. In view of this, a variety of alternative techniques have been developed to induce pluripotency in somatic cells. This review provides an overview on current reprogramming protocols, discusses their pros and cons and future challenges to provide safe and transgene-free iPSCs.
Keywords
REPROGRAMMING FACTORS, HUMAN FIBROBLASTS, RECOMBINANT PROTEINS, cellular reprogramming, EMBRYONIC STEM-CELLS, XENO-FREE CONDITIONS, induction methods, induced pluripotent stem cells, NUCLEAR TRANSFER, DEFINED FACTORS, MESSENGER-RNA, IPS CELLS, INDUCTION

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 249.16 KB

Citation

Please use this url to cite or link to this publication:

MLA
Tavernier, Geertrui, Barbara Mlody, Jo Demeester, et al. “Current Methods for Inducing Pluripotency in Somatic Cells.” ADVANCED MATERIALS 25.20 (2013): 2765–2771. Print.
APA
Tavernier, G., Mlody, B., Demeester, J., Adjaye, J., & De Smedt, S. (2013). Current methods for inducing pluripotency in somatic cells. ADVANCED MATERIALS, 25(20), 2765–2771.
Chicago author-date
Tavernier, Geertrui, Barbara Mlody, Jo Demeester, James Adjaye, and Stefaan De Smedt. 2013. “Current Methods for Inducing Pluripotency in Somatic Cells.” Advanced Materials 25 (20): 2765–2771.
Chicago author-date (all authors)
Tavernier, Geertrui, Barbara Mlody, Jo Demeester, James Adjaye, and Stefaan De Smedt. 2013. “Current Methods for Inducing Pluripotency in Somatic Cells.” Advanced Materials 25 (20): 2765–2771.
Vancouver
1.
Tavernier G, Mlody B, Demeester J, Adjaye J, De Smedt S. Current methods for inducing pluripotency in somatic cells. ADVANCED MATERIALS. 2013;25(20):2765–71.
IEEE
[1]
G. Tavernier, B. Mlody, J. Demeester, J. Adjaye, and S. De Smedt, “Current methods for inducing pluripotency in somatic cells,” ADVANCED MATERIALS, vol. 25, no. 20, pp. 2765–2771, 2013.
@article{4109718,
  abstract     = {The groundbreaking discovery of reprogramming fibroblasts towards pluripotency merely by introducing four transcription factors (OCT4, SOX2, KLF4 and c-MYC) by means of retroviral transduction has created a promising revolution in the field of regenerative medicine. These so-called induced pluripotent stem cells (iPSCs) can provide a cell source for disease-modelling, drug-screening platforms, and transplantation strategies to treat incurable degenerative diseases, while circumventing the ethical issues and immune rejections associated with the use of non-autologous embryonic stem cells. The risk of insertional mutagenesis, caused both by the viral and transgene nature of the technique has proven to be the major limitation for iPSCs to be used in a clinical setting. In view of this, a variety of alternative techniques have been developed to induce pluripotency in somatic cells. This review provides an overview on current reprogramming protocols, discusses their pros and cons and future challenges to provide safe and transgene-free iPSCs.},
  author       = {Tavernier, Geertrui and Mlody, Barbara and Demeester, Jo and Adjaye, James and De Smedt, Stefaan},
  issn         = {0935-9648},
  journal      = {ADVANCED MATERIALS},
  keywords     = {REPROGRAMMING FACTORS,HUMAN FIBROBLASTS,RECOMBINANT PROTEINS,cellular reprogramming,EMBRYONIC STEM-CELLS,XENO-FREE CONDITIONS,induction methods,induced pluripotent stem cells,NUCLEAR TRANSFER,DEFINED FACTORS,MESSENGER-RNA,IPS CELLS,INDUCTION},
  language     = {eng},
  number       = {20},
  pages        = {2765--2771},
  title        = {Current methods for inducing pluripotency in somatic cells},
  url          = {http://dx.doi.org/10.1002/adma.201204874},
  volume       = {25},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: